Iovance conditional Australia OK for in previously treated unresectable or metastatic melanoma
Iovance wins conditional TGA approval in Australia for Amtagvi (lifileucel) in previously treated unresectable or metastatic melanoma, third global authorization
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.